PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
65.08%
Positive revenue growth while AR is negative. John Neff might see a notable competitive edge here.
113.05%
Positive gross profit growth while AR is negative. John Neff would see a clear operational edge over the competitor.
348.34%
Positive EBIT growth while AR is negative. John Neff might see a substantial edge in operational management.
348.34%
Positive operating income growth while AR is negative. John Neff might view this as a competitive edge in operations.
220.00%
Positive net income growth while AR is negative. John Neff might see a big relative performance advantage.
219.88%
Positive EPS growth while AR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
216.96%
Positive diluted EPS growth while AR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.03%
Slight or no buyback while AR is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
0.18%
Dividend growth of 0.18% while AR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
48.38%
OCF growth above 1.5x AR's 7.56%. David Dodd would confirm a clear edge in underlying cash generation.
72.42%
FCF growth above 1.5x AR's 15.38%. David Dodd would verify if the firm’s strategic investments yield superior returns.
5.78%
10Y revenue/share CAGR under 50% of AR's 226.56%. Michael Burry would suspect a lasting competitive disadvantage.
-30.01%
Negative 5Y CAGR while AR stands at 76.73%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-56.16%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
28.20%
Below 50% of AR's 266.41%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-39.36%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
141.84%
Net income/share CAGR at 50-75% of AR's 196.15%. Martin Whitman might question if the firm’s product or cost base lags behind.
164.85%
5Y net income/share CAGR 1.25-1.5x AR's 129.17%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
-34.35%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
379.13%
10Y equity/share CAGR above 1.5x AR's 24.95%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
46.13%
5Y equity/share CAGR above 1.5x AR's 2.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-11.52%
Negative 3Y equity/share growth while AR is at 31.02%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
168.41%
Dividend/share CAGR of 168.41% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-0.71%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-6.37%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
100.00%
Inventory growth of 100.00% while AR is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
3.34%
Positive asset growth while AR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.58%
BV/share growth above 1.5x AR's 1.35%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.15%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-32.71%
We cut SG&A while AR invests at 24.05%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.